Fig. 3From: A regimen based on the combination of trimethoprim/sulfamethoxazole with caspofungin and corticosteroids as a first-line therapy for patients with severe non-HIV-related pneumocystis jirovecii pneumonia: a retrospective study in a tertiary hospitalThe life cycle of pneumocystis in the lung and the mechanism of synergistic therapy SMX-TMP, sulfamethoxazole-trimethoprimBack to article page